In 1954, a modest filtration company with just a handful of employees, opened for business. The Millipore Filter Company pioneered the use of membrane technology in hundreds of applications. Later changing its name to Millipore Corporation to reflect its growing range of products and expanded core capabilities, the company would expand - through strategic acquisitions, targeted capital investments, and organic growth - to a global, billion dollar Life Science corporation. In 2010, Millipore Corporation was acquired by Merck KGaA, Darmstadt, Germany, and became part of the company’s life science tools division. With a range of more than 60,000 products on offer, this division captures significant opportunities in high-growth, high-margin market segments such as bio-research and bio-production.
As Part of the Merck Group
Merck KGaA, Darmstadt, Germany is a global pharmaceutical, chemical and life science company with a history that began in 1668 and a future shaped by approximately 38,000 employees in 66 countries. The company’s subsidiaries in North America operate using the umbrella brand "EMD."
September 22, 2014 Merck agrees to acquire Sigma-Aldrich.
August 26, 2014
Merck Millipore expands Biomanufacturing Sciences and Training Center in Japan and announces opening of new location in Tokyo.
May 1, 2014
Udit Batra becomes CEO and President of Merck Millipore.
July 12, 2013
Merck Millipore opens new R&D Center in Darmstadt, Germany, expanding capabilities in bioavailability enhancement and oral dosage formulation.
September 20, 2012
Merck Millipore opens state-of-the-art Biodevelopment Centre in Martillac, France, which provides customers with access to the latest process technologies, increasing speed to clinic and productivity.
August 22, 2012
Merck Millipore acquires cell culture media specialist Biochrom AG. The acquisition rounds out Merck Millipore’s portfolio of media and buffers used in biopharmaceutical production.
August 30, 2011
Merck Millipore strengthens its Bioscience Business by acquiring Amnis Corporation. This acquisition adds world-class cell imaging capabilities in the fast growing flow cytometry market.
August 1, 2011
Merck Millipore acquires Biotest AG’s microbiology business.The acquisition strengthens Merck Millipore’s leading position in microbiology industry segment.